Cambrian Biopharma is a Distributed Development Company (DisCo) that focuses on developing therapies and medicines to treat specific diseases and improve overall quality of life. Their goal is to lengthen healthspan, the period of life spent in good health, by targeting biological drivers of aging. By first treating specific diseases and then deploying them as preventative medicines, Cambrian aims to modernize healthcare in the 21st century. Their approach enables scientists to translate their discoveries from the lab to the clinic, bringing much-needed medicines to patients.